Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that it’s wholly owned subsidiary, Dr Reddy’s Laboratories, Inc is continuing its voluntary nationwide recall of lot ABD807 of Levetiracetram in 0.54% Sodium Chloride Injection, 1,500 mg/100 mL (15 mg/mL) single-dose infusion bags to the hospital level in U.S.A.
View the full article from the FDA.
Dr. Reddy's Laboratories Continues its Voluntary Nationwide Recall of L
No replies to this topic
0 user(s) are reading this topic
0 members, 0 guests, 0 anonymous users